Protective properties of kefir on burn wounds of mice that were infected with S. aureus, P. auroginasa and E. coli

Yükleniyor...
Küçük Resim

Tarih

2019

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Yayıncı

Cellular and Molecular Biology (CMB)

Erişim Hakkı

info:eu-repo/semantics/openAccess

Özet

Burns and burn wounds are very sensitive to infections and cause a large amount of death worldwide. Although burn wound is sterile at the beginning, because of the risk factors such as prolonged hospital stay, immune suppression and burn affecting large surface area, colonisation with Staphylococcus aureus, Pseudomonas aeruginosa and Escherichia coli occur. For the burn therapy, one of the most important ways is to control bacterial infections. A probiotic fermented milk product kefir has antioxidant, antimicrobial, antiinflammatory, anticancer and various health promoting features. This study aims to examine possible protective properties of kefir which was used on the burn wounds that were infected with S. aureus, P. auroginasa and E. coli. Swiss albino / Balb-c mice were seperated into four groups: (1) used as control group, (2) second-degree burn model+ burn wounds were infected with P.aeruginosa + S.aureus + E.coli, (3) second-burn wounds were treated with sterile pads dressed with kefir and (4) second-degree burn+burn wounds were infected with P. aeruginosa + S.aureus +E.coli before being treated with sterile pads dressed with kefir. The serum biochemical results verified the histopathological results and our findings showed that kefir is an effective product with cell-protecting properties.

Açıklama

Anahtar Kelimeler

E.coli; Infections; Kefir; Mice.; P.aeruginosa; S.aureus; Second-degree burn; Wound healing.

Kaynak

Cellular and Molecular Biology (CMB)

WoS Q Değeri

Q4

Scopus Q Değeri

N/A

Cilt

65

Sayı

7

Künye

Cetik Yildiz S, Demir C, Cengiz M, Ayhanci A. Protective properties of kefir on burn wounds of mice that were infected with S. aureus, P. auroginasa and E. coli. Cell Mol Biol (Noisy-le-grand). 2019 Sep 30;65(7):60-65. PMID: 31880519.